Covestor LTD Biotechnology

Covestor LTD

$160 Million
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
MGNX Macrogenics Inc	$195M	$0 0.0% of portfolio	16	Q3 2024 Added 166.67%
MNKD Mannkind Corp	$1.76B	$0 0.0% of portfolio	22	Q3 2024 Reduced 4.35%
MDXG Mimedx Group, Inc.	$1.03B	$0 0.0% of portfolio	54	Q3 2024 Reduced 98.92%
NAUT Nautilus Biotechnology, Inc.	$219M	$0 0.0% of portfolio	7	Q4 2023 Added 40.0%
NKTR Nektar Therapeutics	$174M	$0 0.0% of portfolio	5	Q2 2024 Reduced 80.0%
NRIX Nurix Therapeutics, Inc.	$935M	$0 0.0% of portfolio	5	Q3 2024 Reduced 28.57%
NUVB Nuvation Bio Inc.	$582M	$0 0.0% of portfolio	34	Q3 2024 Reduced 5.56%
OCUL Ocular Therapeutix, Inc	$654M	$0 0.0% of portfolio	14	Q3 2024 Reduced 41.67%
OLMA Olema Pharmaceuticals, Inc.	$247M	$0 0.0% of portfolio	7	Q1 2024 New
PMCB Pharma Cyte Biotech, Inc.	$34M	$0 0.0% of portfolio	226	Q4 2023 Added 19.58%
PLRX Pliant Therapeutics, Inc.	$643M	$0 0.0% of portfolio	5	Q3 2024 Reduced 16.67%
PRTA Prothena Corp Public LTD CO	$714M	$0 0.0% of portfolio	4	Q1 2024 Added 33.33%
PTCT Ptc Therapeutics, Inc.	$3.31B	$0 0.0% of portfolio	5	Q1 2024 Reduced 16.67%
RAPT Rapt Therapeutics, Inc.	$24.6M	$0 0.0% of portfolio	23	Q3 2024 Added 130.0%
RXRX Recursion Pharmaceuticals, Inc.	$1.09B	$0 0.0% of portfolio	12	Q3 2024 Reduced 7.69%
RGNX Regenxbio Inc.	$329M	$0 0.0% of portfolio	7	Q3 2024 Added 75.0%
RLAY Relay Therapeutics, Inc.	$500M	$0 0.0% of portfolio	11	Q1 2024 Reduced 8.33%
REPL Replimune Group, Inc.	$616M	$0 0.0% of portfolio	11	Q1 2024 Added 83.33%
RVNC Revance Therapeutics, Inc.	$212M	$0 0.0% of portfolio	24	Q3 2024 Reduced 7.69%
RYTM Rhythm Pharmaceuticals, Inc.	$3.13B	$0 0.0% of portfolio	3	Q1 2024 Reduced 25.0%
RCKT Rocket Pharmaceuticals, Inc.	$875M	$0 0.0% of portfolio	6	Q1 2024 Reduced 14.29%
SAGE Sage Therapeutics, Inc.	$333M	$0 0.0% of portfolio	6	Q3 2024 Reduced 14.29%
SANA Sana Biotechnology, Inc.	$314M	$0 0.0% of portfolio	14	Q3 2024 Reduced 6.67%
SRRK Scholar Rock Holding Corp	$2.31B	$0 0.0% of portfolio	7	Q1 2024 New
SWTX Spring Works Therapeutics, Inc.	$2.22B	$0 0.0% of portfolio	4	Q1 2024 Reduced 20.0%
SNDX Syndax Pharmaceuticals Inc	$740M	$0 0.0% of portfolio	4	Q3 2024 Reduced 20.0%
TNGX Tango Therapeutics, Inc.	$273M	$0 0.0% of portfolio	9	Q3 2024 Reduced 10.0%
TARS Tarsus Pharmaceuticals, Inc.	$1.41B	$0 0.0% of portfolio	3	Q1 2024 New
TGTX Tg Therapeutics, Inc.	$4.68B	$0 0.0% of portfolio	8	Q3 2024 Reduced 27.27%
TBPH Theravance Biopharma, Inc.	$640M	$0 0.0% of portfolio	31	Q3 2024 Reduced 50.0%
TVTX Travere Therapeutics, Inc.	$1.1B	$0 0.0% of portfolio	11	Q2 2024 Reduced 8.33%
TYRA Tyra Biosciences, Inc.	$588M	$0 0.0% of portfolio	6	Q2 2024 New
VTYX Ventyx Biosciences, Inc.	$127M	$0 0.0% of portfolio	28	Q3 2024 Added 115.38%
VERA Vera Therapeutics, Inc.	$1.15B	$0 0.0% of portfolio	2	Q3 2024 Reduced 33.33%
VCYT Veracyte, Inc.	$2.93B	$0 0.0% of portfolio	13	Q3 2024 Reduced 40.91%
VERV Verve Therapeutics, Inc.	$344M	$0 0.0% of portfolio	13	Q3 2024 Reduced 7.14%
VIR Vir Biotechnology, Inc.	$974M	$0 0.0% of portfolio	11	Q3 2024 Reduced 8.33%
VRDN Viridian Therapeutics, Inc.\De	$759M	$0 0.0% of portfolio	7	Q3 2024 Reduced 12.5%
ZNTL Zentalis Pharmaceuticals, Inc.	$171M	$0 0.0% of portfolio	21	Q3 2024 Added 200.0%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.